Mononucleosis has no cure and no reliably effective antiviral drug, so treatment is almost entirely supportive: rest, fluids, and over-the-counter pain relievers to manage symptoms while your body clears the infection on its own. Most people feel significantly better within two to four weeks, though fatigue can linger for months. The simplicity of the treatment plan hides some real decisions, though, particularly around which medications to avoid, when it is safe to be physically active again, and what complications deserve a trip to the emergency room.
Why Rest Is the Real Treatment
Epstein-Barr virus, the cause of roughly nine out of ten mono cases, triggers a massive immune response. Your body redirects enormous energy toward fighting the virus, which is why fatigue during mono can feel unlike anything you have experienced before. No drug shortens this process in a meaningful way. The practical prescription is unglamorous: sleep as much as your body asks for, stay hydrated, and avoid pushing through exhaustion. Bed rest in the strict, old-fashioned sense is not required for everyone, but most people find that even light daily activities wipe them out during the first couple of weeks.
The tricky part is that “rest” does not come with a clear end date. Some people bounce back within two weeks; others feel drained for two or three months. Roughly one in ten people still report significant fatigue six months after getting sick.1Journal of Rehabilitation Therapy. Predictors for Developing Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome following Infectious Mononucleosis The best general advice is to let symptoms guide activity: if you feel worse the day after doing something, you did too much. Gradual increases in activity work better than trying to power through.
Managing Pain and Fever
Mono typically brings a sore throat that can rival strep, along with fever, headaches, and body aches. Acetaminophen and ibuprofen are the standard recommendations for keeping these symptoms tolerable. There is some evidence that NSAIDs may do more than just take the edge off. A case series in patients with allergic tendencies found that NSAIDs resolved fever, headache, and fatigue quickly after acetaminophen alone had failed.2PubMed Central. Nonsteroidal Anti-Inflammatory Drugs Quickly Resolve Symptoms Associated with EBV-Induced Infectious Mononucleosis in Patients with Atopic Predispositions That is a small report, not a large trial, so it would be premature to call NSAIDs a game-changer. Still, if acetaminophen is not cutting it for your sore throat or fever, ibuprofen or naproxen is a reasonable next step.
Gargling with salt water, sucking on ice chips, and drinking cool fluids can also soothe a swollen throat. Some people find that their throat is so painful they struggle to eat. Soft, cool foods and adequate fluids matter more than hitting your normal calorie intake during the worst days. If you cannot swallow liquids at all, that is a reason to seek medical attention, because severe tonsil swelling can threaten the airway.
Antibiotics and the Infamous Rash
Mono is a viral infection, so antibiotics do nothing against it. The trouble is that mono’s sore throat looks a lot like strep throat, and rapid strep tests occasionally come back positive even during mono (some people carry strep bacteria without it being the cause of their illness). When a doctor prescribes amoxicillin or ampicillin for what they believe is strep and the patient actually has mono, a widespread rash often follows. Older textbooks claimed this happened to about 90% of mono patients given ampicillin. More recent data put the rate for amoxicillin at closer to 30%.3Pediatrics. Incidence of Rash After Amoxicillin Treatment in Children With Infectious Mononucleosis That is still high enough to be a real concern.
The rash itself is usually a blotchy, red, non-itchy eruption that spreads across the trunk and arms. For a long time, doctors assumed it was a harmless interaction between the virus and the drug rather than a true allergic reaction. Recent research has challenged that assumption. Skin testing in patients who developed the rash found that most had genuine drug sensitization to the antibiotic, meaning they could potentially have a real allergic reaction if they took it again in the future.4PubMed Central. Amoxicillin rash in patients with infectious mononucleosis: evidence of true drug sensitization If you developed a rash on amoxicillin during mono, it is worth mentioning to future doctors rather than dismissing it as “just the mono rash.” Allergy testing can help sort out whether you need to avoid penicillin-type drugs going forward.
Antivirals Do Not Help Much
Acyclovir and valacyclovir work well against some other herpes-family viruses, so researchers have tested them against Epstein-Barr virus repeatedly. The results have been consistently underwhelming. A Cochrane review pooling data from multiple trials found that antiviral treatment shaved roughly five days off the time to recovery as judged by physicians, but the confidence around that number was wide, and the reviewers noted that since mono symptoms often take a month or more to clear on their own, a five-day difference might not matter much in practice.5PubMed Central. Antiviral agents for infectious mononucleosis (glandular fever) A separate meta-analysis of acyclovir trials found a trend toward benefit but no statistically significant improvement in clinical outcomes.6PubMed. Acyclovir for treatment of infectious mononucleosis: a meta-analysis
One early double-blind trial did find that when researchers combined several symptom measures together into a composite score, acyclovir showed a statistically significant effect. But no individual symptom improved on its own.7PubMed. Effect of acyclovir on infectious mononucleosis: a double-blind, placebo-controlled study The pattern across the whole body of research is consistent: antivirals suppress viral shedding in the throat, but this does not translate into patients feeling meaningfully better, faster. Most guidelines do not recommend antivirals for routine mono.
When Steroids Make Sense
Corticosteroids like prednisone are powerful anti-inflammatory drugs, and they can dramatically reduce tonsil swelling. Given how miserable the sore throat of mono can be, it is tempting to reach for them. But routine use of steroids for mono is not recommended. They suppress the immune system at a time when your body is actively fighting a virus, and evidence that they speed overall recovery is weak.
Steroids are reserved for serious complications. The main scenario is airway obstruction: when the tonsils swell so much that breathing becomes difficult. Severe drops in platelet count and significant destruction of red blood cells are other situations where the risk-benefit calculation shifts in favor of steroids.8PubMed Central. Corticosteroids for infectious mononucleosis Even for these indications, there are no well-established dosing guidelines, and treatment is essentially based on clinical judgment.9US Pharmacist. Management Options for Infectious Mononucleosis If a doctor prescribes a short steroid course for your mono, it likely means they are concerned about a specific complication, not just trying to make you more comfortable.
The Spleen Problem and Getting Back to Activity
Your spleen enlarges during mono as it works overtime filtering infected blood cells. An enlarged spleen is fragile, and a blow to the abdomen, or sometimes even no trauma at all, can cause it to rupture. Splenic rupture is rare but it is the most feared complication of mono because it can cause life-threatening internal bleeding. A systematic review of published cases found that the average patient who experienced splenic rupture was around 22 years old, and about 70% were male. Only 14% of cases had a clear history of preceding trauma, meaning the spleen sometimes ruptures without an obvious hit.10PubMed. Splenic rupture in infectious mononucleosis: A systematic review of published case reports
Timing matters. The average time from the start of mono symptoms to splenic rupture is about two weeks, and roughly 90% of ruptures happen within the first month.11PubMed Central. Association of Splenic Rupture and Infectious Mononucleosis: A Retrospective Analysis and Review of Return-to-Play Recommendations Some cases have been reported as late as eight weeks after symptom onset.10PubMed. Splenic rupture in infectious mononucleosis: A systematic review of published case reports The mortality rate for splenic rupture associated with mono is around 5%.12PubMed Central. Splenic Rupture in Infectious Mononucleosis: A Case Report
This is why doctors tell you to avoid contact sports and heavy lifting during and after mono. The general consensus is to wait at least three to four weeks from diagnosis before gradually returning to physical activity, and only if you are fever-free, well hydrated, and your spleen is not palpable on exam.13PubMed. Determination of safe return to play for athletes recovering from infectious mononucleosis: a review of the literature For athletes in contact or collision sports, the stakes are higher. Ultrasound can check whether the spleen has returned to normal size, but “normal” spleen size varies a lot from person to person, and there is no single test that definitively says it is safe to play.14PubMed Central. Return to Play After Infectious Mononucleosis Return-to-play decisions are ultimately individualized. Light aerobic exercise like walking is generally fine once the acute illness has passed. The concern is really about blows to the abdomen and heavy straining.
Complications Worth Knowing About
Most people recover from mono without drama, but the virus can occasionally cause problems beyond the classic sore throat, fatigue, and swollen glands.
Airway obstruction from massively swollen tonsils is the complication that brings people to the emergency room. In a hospital study of 467 mono patients, only five developed potentially dangerous airway obstruction, and of those, only two did not respond to steroid treatment.15PubMed Central. Airway compromise in infectious mononucleosis: a case report In rare cases where steroids fail, surgery to remove the tonsils or intubation becomes necessary. Warning signs include noisy breathing, drooling because swallowing is impossible, and feeling short of breath while lying flat.
Liver involvement is more common than most people realize. Elevations in liver enzymes occur frequently during mono and are usually mild and temporary.16PubMed Central. Infectious mononucleosis and hepatic function Occasionally the liver inflammation is significant enough to cause jaundice. If your eyes or skin turn yellow, or if you develop pain in the upper right part of your abdomen, get checked out. Avoiding alcohol during recovery is wise, since your liver is already under stress.
Neurological complications are uncommon but well documented. Epstein-Barr virus has been linked to inflammation of the brain, meningitis, and various nerve-related problems. These can sometimes appear even without the typical sore throat and swollen glands that tip people off to mono.17Pediatric Neurology. Neurologic complications of infectious mononucleosis Severe headache with neck stiffness, sudden weakness in a limb, or changes in vision during a bout of mono warrant urgent evaluation.
When Fatigue Becomes Chronic
The most frustrating aspect of mono for many people is not the acute illness but the fatigue that follows. A prospective study tracking adolescents after mono found that 13% met criteria for chronic fatigue syndrome six months later. By 12 months, that number had dropped to 7%, and by 24 months it was 4%.18PubMed Central. Chronic Fatigue Syndrome Following Infectious Mononucleosis in Adolescents: A Prospective Cohort Study All 13 adolescents still meeting chronic fatigue criteria at the two-year mark were female, and they had reported more severe fatigue at 12 months, suggesting that the trajectory of fatigue recovery can signal who is most at risk for prolonged illness.
There is no proven way to prevent post-mono chronic fatigue, and no medication that reliably treats it. Gradual increases in activity, good sleep habits, and managing expectations seem to be the most helpful approach. Pushing too hard too early is often counterproductive. If fatigue persists beyond a few months, it is reasonable to revisit a doctor to rule out other causes like thyroid dysfunction or iron deficiency, which can mimic or compound post-viral fatigue.
Getting the Diagnosis Right
Treatment decisions depend on a correct diagnosis, and mono is not always straightforward to confirm. The classic rapid test, often called a Monospot, detects heterophile antibodies and works well in teenagers and adults. In adolescents it has high accuracy. But in young children, particularly those under four, the test has poor sensitivity and frequently gives false negatives. Children in that age group need virus-specific blood tests, which take longer and cost more but can actually confirm or rule out the infection.19PubMed. How to use … the Monospot and other heterophile antibody tests
It is also worth knowing that Epstein-Barr virus is not the only virus that causes a mono-like illness. Cytomegalovirus can produce a very similar picture with fever, fatigue, and swollen lymph nodes, though sore throat tends to be less prominent.20PubMed Central. Comparative Clinical Characteristics of Cytomegalovirus and Epstein-Barr Virus Mononucleosis in Immunocompetent Hosts: Experience from a Tropical Setting If a Monospot comes back negative but your symptoms fit, your doctor may test for CMV or order EBV-specific serology. The treatment approach is similar regardless of the virus, but knowing which one you have matters for understanding your immune status and future risk.
The Vaccine Horizon
Given that most treatment is limited to symptom management, preventing mono in the first place would be the real prize. Vaccine development against Epstein-Barr virus has been slow but is gaining momentum. The only phase 2 vaccine trial completed in humans used a protein from the virus’s outer surface. It reduced the rate of symptomatic mononucleosis in people who had not previously been exposed to EBV, but it did not prevent EBV infection itself, meaning people still caught the virus without getting sick.21PubMed Central. The need and challenges for development of an Epstein-Barr virus vaccine Since EBV has also been linked to certain cancers and, more recently, to multiple sclerosis risk, the motivation to develop an effective vaccine extends well beyond preventing a few weeks of sore throat. Several new candidates using modern vaccine platforms are in early-stage trials, though a widely available vaccine is likely still years away.